CFO
BCPC

Callan Family Office’s Balchem Corp BCPC Stock Holding History

Callan Family Office’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$864K Buy
5,096
+870
+21% +$148K 0.02% 605
2025
Q4 		$648K Buy
+4,226
New +$645K 0.01% 687

Other funds holding BCPC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Callan Family Office's BCPC Position: Q1 2026 in Review

Callan Family Office increased its Balchem Corp (BCPC) stake by 21% in Q1 2026, buying an estimated $148K and bringing the position to 5,096 shares worth $864K. The position accounts for 0.02% of the portfolio, ranked #605.

Callan Family Office first reported a position in BCPC in Q4 2025 and has held it in 2 quarters since. 422 funds tracked by Wall St. Rank hold BCPC as of Q1 2026.

  • Callan Family Office held 5,096 shares of Balchem Corp worth $864K as of Q1 2026.
  • Callan Family Office bought 870 Balchem Corp shares in Q1 2026, an estimated $148K.
  • Balchem Corp made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #605 holding.
  • Callan Family Office first reported a position in Balchem Corp in Q4 2025 and has held it in 2 quarters since.
  • 422 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.